Age, yrs (mean) | | 63.2 ± 13.8 |
Gender, no. of patients (%) | Male | 133 (81.6) |
| Female | 30 (18.4) |
No. of tumors (%) | Single | 96 (58.9) |
| Multiple | 67 (41.1) |
Tumor size (%) | <3 cm | 89 (54.6) |
| ≥3 cm | 74 (45.4) |
Grade, no. of patients (%) | G1 | 53 (32.5) |
| G2 | 86 (52.8) |
| G3 | 24 (14.7) |
T Stage | Ta | 61 (37.4) |
| T1 | 102 (62.6) |
Intravesical treatment, no. of patients (%) | No | 83 (50.9) |
| Yes | 80 (49.1) |
Recurrence-free survival, months (median) | | 43.9 (6.1~171.5) |
Recurrence, no. of patients (%) | No | 107 (65.6) |
| Yes | 56 (34.4) |
Progression free survival, months (median) | | 52.3 (6.6~164.9) |
Progression, no. of patients (%) | No | 145 (89.0) |
| Yes | 18 (11.0) |